ESR1 and breast cancer: Hypermethylation of ERα gene was reported to be an important cause of suppressed ERα expression (9, 11), and the combination of DNA demethylating agents with HDAC inhibitors would restore ERα expression and TAM sensitivity in ERα− BC cells (12, 13).